Shelter Pharma Ltd - 543963 - Clarification Sought By BSE Limited ('BSE') For Significant Increase In Price/Movement Of Securities Of The Company
With reference to clarification sought from company in relation to increase/spurt in price/volume of the securities of the company , clarification is attached herewith Shelter Pharma Ltd - 543963 - Clarification sought from Shelter Pharma Ltd
The Exchange has sought clarification from Shelter Pharma Ltd on January 11, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. Shelter Pharma Ltd - 543963 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order
Shelter Pharma Limited has secured a noteworthy order from Taha Drugs & Chemicals co. Ltd - Sudan, for All vitamin Tablets Nutraceuticals and Joemega Capsules Nutraceuticals worth Rupees 1 crore ( Approx) Shelter Pharma Ltd - 543963 - Non-Applicability Of Regulation 23(9) As Per Regulation 15 Of Chapter IV Of SEBI (LODR) Regulations, 2015 For The Half Year Ended September-2023
Declaration regarding Non applicability of Regulation 23(9) of SEBI(LODR) Regulation 2015 Shelter Pharma Ltd - 543963 - Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 Regarding Appointment Of CA Mohammadaltaf Rasulbhai Sachora (ALTAF SACHORA & CO), FRN NO: 138017W Chartered Accountants As Internal Auditor.
Appointment of Internal Auditor For Financial year 2023-2024 Shelter Pharma Ltd - 543963 - Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 Regarding Appointment Of M/S. Murtuza Mandorwala & Associates As Secretarial Auditor
Appointment of Secretarial Auditor for Financial Year 2023-2024 Shelter Pharma Ltd - 543963 - Statement Of Deviation Or Variation In The Use Of Proceeds Of Equity Issue For The Quarter Ended September 30, 2023
Statement of Deviation or variation in the use of proceeds of Equity Issue for the quarter ended September, 2023 Shelter Pharma Ltd - 543963 - Submission Of Standalone Unaudited Financial Results For The Half Year Ended On 30.09.2023 And Disclosure Pursuant To Regulation 33 Of SEBI (LODR) Regulations, 2015.
Submission of Half Yearly result as on 30th September, 2023 Shelter Pharma Ltd - 543963 - Board Meeting Outcome for Outcome Of Board Meeting Held Today On 10Th November, 2023
This is to inform you that, the Board of Directors at their meeting held on today i.e. 10th November, 2023 at 02:30 P.M. at Shelter Nagar, Nr. S. T. Bus Stand, Himmatnagar GJ 383001 IN, interalia considered and approved the following matter: 1. Approval of Standalone Unaudited Financial Result for the Half Year ended on 30th September, 2023 as per Regulation 33 of the SEBI (LODR) Regulations, 2015 along with Limited Review report; 2. Appointment of M/s. Murtuza Mandorwala & Associates, Practicing Company Secretary, as Secretarial Auditor of the Company for the Year 2023-24; 3. Appointment of CA Mohammadaltaf Rasulbhai Sachora (ALTAF SACHORA & CO), FRN NO: 138017W, Ahmedabad , as Internal Auditors of the Company to conduct the Internal Audit for the financial year 2023-24. The Board Meeting started at 02:30 P.M. and ended on 03:15 P.M. Shelter Pharma Ltd - 543963 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 10Th November, 2023
Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 ,inter alia, to consider and approve 1. To consider, approve and take on record the Unaudited Standalone Financial Result of the Company for the Half Year Ended on 30th September, 2023 as per Regulation 33 of the SEBI (LODR) Regulation, 2015; 2. Such Other agendas as may be considered necessary with the permission of the chair.